Quotient Sciences, a global drug development and manufacturing accelerator, has integrated drug substance into its flagship Translational Pharmaceutics platform. The newly integrated service unites drug substance, drug product and clinical testing activities all within a unified organization and under a single project manager.   The full integration of drug substance R&D and manufacturing follows a year after the company’s acquisition of its Alnwick, UK site and provides a more streamlined...